S&P 500
7,716.60
-0.43%
Dow Jones
53,442.20
-0.04%
Nasdaq 100
29,593.80
-1.36%
Russell 2000
3,040.77
-0.56%
FTSE 100
10,769.00
+0.30%
Nikkei 225
67,003.70
-2.87%

Investing

KLRA logo Kailera Therapeutics, Inc. Common Stock : KLRA

KLRA

Stock Data

$18.70

Change up

$0.19 (1.03%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Kailera Therapeutics, Inc. is a biotechnology company focused on developing innovative gene therapies for rare genetic diseases, leveraging advanced technologies to address unmet medical needs. The company's proprietary platform is designed to enhance the precision and effectiveness of therapeutic interventions, targeting various genetic disorders. By collaborating with leading research institutions and leveraging a robust intellectual property portfolio, Kailera aims to bring transformative treatments to patients and position itself as a leader in the gene therapy market. As it advances its product pipeline, Kailera is committed to delivering sustainable value to its investors and stakeholders.

All KLRA Articles

1 Article